10 recruiting, 5 completed, 3 unknown, 2 terminated. 24 Phase 2, 9 Phase 1, 4 Phase 3.
Follow Pediatric Cancer: new trials by email Literature Review of Pediatric Cancer trials Research Report on Pediatric Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Sonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemia sonrotoclax, Azacitidine, Inotuzumab ozogamicin - Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia | Phase 1 / Phase 2 | Not yet recruiting | BeOne Medicines | 30 | 2026-12-01 | 2026-10-26 |
| Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG). BCB-276 - Diffuse Intrinsic Pontine Glioma, DIPG | Phase 2 | Recruiting | BrainChild Bio, Inc | 75 | 2026-09-04 | 2026-10-28 |
| Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE) Selpercatinib Monotherapy, 131I Therapy - Differentiated Thyroid Cancer, Pediatric Cancer | Phase 2 | Recruiting | Children's Hospital of Philadelphia | 13 | 2024-07-29 | 2026-07-24 |
| Effectiveness of Pucotenlimab Combined With Standard Chemotherapy Regimen Pucotenlimab - Rhabdomyosarcoma, Pediatric Cancer | Phase 1 / Phase 2 | Recruiting | Sun Yat-sen University | 82 | 2024-06-06 | 2024-06-13 |
| Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer Larotrectinib monotherapy, 131I therapy - Differentiated Thyroid Cancer, Pediatric Cancer | Phase 2 | Recruiting | Children's Hospital of Philadelphia | 13 | 2024-02-14 | 2026-10-21 |
| Pediatric Oncology Nutrition Intervention Trial Oral Nutrition Supplement, Tube Feed, Cyproheptadine - Pediatric Cancer, Nutrition Related Cancer | Phase 2 / Phase 3 | Completed | Corey Hawes | 20 | 2024-01-31 | 2026-10-08 |
| Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric Cancer Arsenic trioxide - Pediatric Cancer, Li-Fraumeni Syndrome | Phase 2 | Recruiting | Yang Li | 50 | 2023-12-13 | 2024-01-03 |
| Lurbinectedin in FET-Fused Tumors Lurbinectedin - Ewing Sarcoma, Desmoplastic Small Round Cell Tumor | Phase 1 / Phase 2 | Recruiting | Children's Hospital of Philadelphia | 63 | 2023-07-27 | 2026-09-02 |
| Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients Atezolizumab, Sorafenib, Bevacizumab - Refractory Solid Tumor, Hepatocellular Carcinoma | Phase 1 / Phase 2 | Recruiting | St. Jude Children's Research Hospital | 64 | 2022-11-07 | 2026-05-19 |
| Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients Vaccine - Pediatric Cancer | Phase 2 | Recruiting | Wake Forest University Health Sciences | 64 | 2022-08-08 | 2026-07-23 |
| Pediatric Radiation Oncology With Movie Induced Sedation Effect (PROMISE) PROMISE (Pediatric Radiation Oncology with Movie Induced Sedation Effect) - Pediatric Cancer | Phase 2 | Completed | University of Texas Southwestern Medical Center | 30 | 2022-08-01 | 2026-03-02 |
| Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting in Pediatric Patients Fosaprepitant,ondansetron, dexamethasone, placebo ondansetron with dexamethasone - Pediatric Cancer | Phase 2 | Completed | Sun Yat-sen University | 108 | 2022-08-01 | 2024-01-09 |
| Sequential PD-1/PD-L1 Inhibitor and LENvatinib in TLCT and Refractory Hepatoblastoma After Chemotherapy PD-1 inhibitor - Transitional Cell Tumor, Hepatoblastoma | Phase 2 / Phase 3 | Unknown | RenJi Hospital | 15 | 2022-04-10 | 2022-04-11 |
| Comparing TIVA Using Propofol or Dexmedetomidine Versus Sevoflurane During Anaesthesia of Children Undergoing Bone-Marrow Aspiration Sevoflurane, Propofol infusion for maintance, Dexmedetomidine - Invasive Cancer, Pediatric Cancer | Phase 2 / Phase 3 | Completed | Alexandria University | 60 | 2022-02-15 | 2022-12-05 |
| Safety and Efficacy of PEG-rhG-CSF in Preventing Neutropenia in Children With Tumor After Chemotherapy pegylated recombinant human granulocyte-colony stimulating factor - Pediatric Cancer | Phase 2 | Unknown | Sun Yat-sen University | 108 | 2020-10-10 | 2021-09-02 |
| Preventative Skin Care for Children Undergoing Targeted CNS Tumor Therapy Warm Baths or Showers, Moisturizer, SPF 30 or Higher Suncreen - Pediatric Cancer, CNS Tumor, Childhood | Phase 2 | Completed | Dana-Farber Cancer Institute | 14 | 2020-10-01 | 2026-06-12 |
| Famitinib Plus Camrelizumab & Famitinib Alone & Famitinib Plus Ifosfamide in Advanced Osteosarcoma Famitinib, Ifosfamide, Camrelizumab - Effect of Drugs, Progression | Phase 1 / Phase 2 | Withdrawn | Peking University People's Hospital | 2019-08-15 | 2020-05-19 | |
| A Pediatric Trial Using Tranexamic Acid in Thrombocytopenia Tranexamic Acid, Normal saline - Pediatric Cancer, Thrombocytopenia | Phase 1 / Phase 2 | Terminated | Meghan McCormick | 11 | 2019-04-22 | 2021-09-20 |
| Durvalumab and Tremelimumab for Pediatric Malignancies Durvalumab / Tremelimumab Combination Therapy - Pediatric Cancer, Solid Tumor Pediatric | Phase 1 / Phase 2 | Active not recruiting | AstraZeneca | 50 | 2019-03-07 | 2026-09-29 |
| the Efficacy and Safety of Sugammadex in Children 0-2 Years Old Sugammadex - Anesthesia, Pediatric Cancer | Phase 2 / Phase 3 | Unknown | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 62 | 2018-11-15 | 2018-11-02 |
Showing 20 of 24. Sign in to see all of them.
Neoplasms (24) · Central Nervous System Neoplasms (2) · Hepatoblastoma (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Thyroid Neoplasms (2) · Brain Neoplasms (1) · Burkitt Lymphoma (1) · Carcinoma, Hepatocellular (1) · Child Nutrition Disorders (1) · Dermatitis (1) · Desmoplastic Small Round Cell Tumor (1) · Diffuse Intrinsic Pontine Glioma (1) · Disease Progression (1) · Fibrolamellar hepatocellular carcinoma (1) · Hematologic Neoplasms (1)
Neoplasms by Histologic Type (8) · Neoplasms by Site (7) · Hematologic Diseases (5) · Hemic and Lymphatic Diseases (5) · Nervous System Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Disease Attributes (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Genetic Diseases, Inborn (2) · Head and Neck Neoplasms (2) · Immune System Diseases (2)
Cyclophosphamide (3) · Dexamethasone (3) · camrelizumab (2) · AZD 6244 (1) · Arsenic Trioxide (1) · Azacitidine (1) · Bevacizumab (1) · CYC065 (1) · Calcium Dobesilate (1) · Carboplatin (1) · Cyproheptadine (1) · Cytarabine (1) · Dexmedetomidine (1) · Educational Status (1) · Enteral Nutrition (1)
Children's Hospital of Philadelphia (3) · Sun Yat-sen University (3) · Alexandria University (1) · AstraZeneca (1) · BeOne Medicines (1) · BrainChild Bio, Inc (1) · Copenhagen University Hospital, Rigshospitalet (1) · Corey Hawes (1) · Dana-Farber Cancer Institute (1) · Federal Research Institute of Pediatric Hematology, Oncology and Immunology (1) · Gustave Roussy, Cancer Campus, Grand Paris (1) · M.D. Anderson Cancer Center (1) · Meghan McCormick (1) · Peking University People's Hospital (1) · RenJi Hospital (1)
United States (13) · China (6) · Denmark (2) · France (2) · Italy (2) · Netherlands (2) · Spain (2) · United Kingdom (2) · Egypt (1) · Finland (1) · Germany (1) · Russia (1)
Theodore Laetsch, MD (3) · Yizhuo Zhang (2) · Anna Franklin, MD (1) · Anna Konstantinova, MD (1) · Ashley Hinson, MD (1) · Ashok Gupta, MD, PhD (1) · Birgit Geoerger, MD (1) · Corey J Hawes, DCN, RD, CSO, CNSC, LD (1) · Cori Abikoff, MD (1) · Hao Feng (1) · Jennifer Huang, MD (1) · Jessica Gartrell, MD (1) · Kiran A Kumar, MD (1) · Marisa Couluris, DO (1) · Meghan McCormick, MD (1)
PMID 29587881, PMID 31538815, PMID 32005489, PMID 33892407, PMID 34347542, PMID 34533416, PMID 34543871, PMID 35292802, PMID 37183837, PMID 41838385, PMID 42222420, PMID 42686334
2016 (1), 2018 (1), 2023 (1), UL1TR001998 (1)